This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
